Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma

Rajanish Singla, Stephanie King, Kevin Albuquerque, Steve Creech, Nesrin Dogan

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

We assessed the feasibility and impact of simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of left breast carcinoma and compared target coverage and normal tissue doses with SIB-IMRT and 3-dimensional (3D) conformal RT using opposed tangential fields. For each of 10 patients with early-stage left-sided invasive breast carcinoma, 5 plans were generated; the first 4 were 3D conformal opposed tangential fields-2 with wedges, 2 with compensators and either photon or electron boost. A dose of 50.4 Gy in 28 fractions was prescribed to the left breast and an additional 16 Gy in 8 fractions to the lumpectomy bed. When compared to the tangential plans, SIB-IMRT maintained coverage (V95%) to the left breast and lumpectomy bed without significantly increasing the left breast maximum dose. SIB-IMRT was able to reduce the lung mean dose, maximum dose, and the V20 by 55-104 cGy, 983-1298 cGy (p < 0.001), and 3.7-4.4%, respectively. In addition, SIB-IMRT reduced the maximum heart dose by 1032-1173 cGy and contralateral breast dose was increased (although p = NS). The mean and maximum dose to the unspecified tissues was also significantly reduced by 81-88 cGy and 516-942 cGy, respectively. SIB-IMRT resulted in a significant improvement in target dose conformality by up to 67%. Our findings that SIB-IMRT could improve dose conformality, reduce total treatment times, and reduce some of the normal structure doses presents it as an alternative technique for adjuvant breast radiotherapy; however this needs to be studied further in the clinic setting.

Original languageEnglish (US)
Pages (from-to)190-196
Number of pages7
JournalMedical Dosimetry
Volume31
Issue number3
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

acceleration (physics)
breast
radiation therapy
Radiotherapy
cancer
Breast Neoplasms
dosage
Breast
Segmental Mastectomy
Therapeutics
Adjuvant Radiotherapy
beds
Photons
Electrons
compensators
Lung
lungs
wedges

Keywords

  • Breast cancer
  • IMRT
  • Simultaneous-integrated boost

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Health Professions(all)
  • Radiation

Cite this

Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma. / Singla, Rajanish; King, Stephanie; Albuquerque, Kevin; Creech, Steve; Dogan, Nesrin.

In: Medical Dosimetry, Vol. 31, No. 3, 09.2006, p. 190-196.

Research output: Contribution to journalArticle

Singla, Rajanish ; King, Stephanie ; Albuquerque, Kevin ; Creech, Steve ; Dogan, Nesrin. / Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma. In: Medical Dosimetry. 2006 ; Vol. 31, No. 3. pp. 190-196.
@article{031d39e9696a4e119f462afbc865ff37,
title = "Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma",
abstract = "We assessed the feasibility and impact of simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of left breast carcinoma and compared target coverage and normal tissue doses with SIB-IMRT and 3-dimensional (3D) conformal RT using opposed tangential fields. For each of 10 patients with early-stage left-sided invasive breast carcinoma, 5 plans were generated; the first 4 were 3D conformal opposed tangential fields-2 with wedges, 2 with compensators and either photon or electron boost. A dose of 50.4 Gy in 28 fractions was prescribed to the left breast and an additional 16 Gy in 8 fractions to the lumpectomy bed. When compared to the tangential plans, SIB-IMRT maintained coverage (V95{\%}) to the left breast and lumpectomy bed without significantly increasing the left breast maximum dose. SIB-IMRT was able to reduce the lung mean dose, maximum dose, and the V20 by 55-104 cGy, 983-1298 cGy (p < 0.001), and 3.7-4.4{\%}, respectively. In addition, SIB-IMRT reduced the maximum heart dose by 1032-1173 cGy and contralateral breast dose was increased (although p = NS). The mean and maximum dose to the unspecified tissues was also significantly reduced by 81-88 cGy and 516-942 cGy, respectively. SIB-IMRT resulted in a significant improvement in target dose conformality by up to 67{\%}. Our findings that SIB-IMRT could improve dose conformality, reduce total treatment times, and reduce some of the normal structure doses presents it as an alternative technique for adjuvant breast radiotherapy; however this needs to be studied further in the clinic setting.",
keywords = "Breast cancer, IMRT, Simultaneous-integrated boost",
author = "Rajanish Singla and Stephanie King and Kevin Albuquerque and Steve Creech and Nesrin Dogan",
year = "2006",
month = "9",
doi = "10.1016/j.meddos.2005.11.001",
language = "English (US)",
volume = "31",
pages = "190--196",
journal = "Medical Dosimetry",
issn = "0958-3947",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma

AU - Singla, Rajanish

AU - King, Stephanie

AU - Albuquerque, Kevin

AU - Creech, Steve

AU - Dogan, Nesrin

PY - 2006/9

Y1 - 2006/9

N2 - We assessed the feasibility and impact of simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of left breast carcinoma and compared target coverage and normal tissue doses with SIB-IMRT and 3-dimensional (3D) conformal RT using opposed tangential fields. For each of 10 patients with early-stage left-sided invasive breast carcinoma, 5 plans were generated; the first 4 were 3D conformal opposed tangential fields-2 with wedges, 2 with compensators and either photon or electron boost. A dose of 50.4 Gy in 28 fractions was prescribed to the left breast and an additional 16 Gy in 8 fractions to the lumpectomy bed. When compared to the tangential plans, SIB-IMRT maintained coverage (V95%) to the left breast and lumpectomy bed without significantly increasing the left breast maximum dose. SIB-IMRT was able to reduce the lung mean dose, maximum dose, and the V20 by 55-104 cGy, 983-1298 cGy (p < 0.001), and 3.7-4.4%, respectively. In addition, SIB-IMRT reduced the maximum heart dose by 1032-1173 cGy and contralateral breast dose was increased (although p = NS). The mean and maximum dose to the unspecified tissues was also significantly reduced by 81-88 cGy and 516-942 cGy, respectively. SIB-IMRT resulted in a significant improvement in target dose conformality by up to 67%. Our findings that SIB-IMRT could improve dose conformality, reduce total treatment times, and reduce some of the normal structure doses presents it as an alternative technique for adjuvant breast radiotherapy; however this needs to be studied further in the clinic setting.

AB - We assessed the feasibility and impact of simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of left breast carcinoma and compared target coverage and normal tissue doses with SIB-IMRT and 3-dimensional (3D) conformal RT using opposed tangential fields. For each of 10 patients with early-stage left-sided invasive breast carcinoma, 5 plans were generated; the first 4 were 3D conformal opposed tangential fields-2 with wedges, 2 with compensators and either photon or electron boost. A dose of 50.4 Gy in 28 fractions was prescribed to the left breast and an additional 16 Gy in 8 fractions to the lumpectomy bed. When compared to the tangential plans, SIB-IMRT maintained coverage (V95%) to the left breast and lumpectomy bed without significantly increasing the left breast maximum dose. SIB-IMRT was able to reduce the lung mean dose, maximum dose, and the V20 by 55-104 cGy, 983-1298 cGy (p < 0.001), and 3.7-4.4%, respectively. In addition, SIB-IMRT reduced the maximum heart dose by 1032-1173 cGy and contralateral breast dose was increased (although p = NS). The mean and maximum dose to the unspecified tissues was also significantly reduced by 81-88 cGy and 516-942 cGy, respectively. SIB-IMRT resulted in a significant improvement in target dose conformality by up to 67%. Our findings that SIB-IMRT could improve dose conformality, reduce total treatment times, and reduce some of the normal structure doses presents it as an alternative technique for adjuvant breast radiotherapy; however this needs to be studied further in the clinic setting.

KW - Breast cancer

KW - IMRT

KW - Simultaneous-integrated boost

UR - http://www.scopus.com/inward/record.url?scp=33746885914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746885914&partnerID=8YFLogxK

U2 - 10.1016/j.meddos.2005.11.001

DO - 10.1016/j.meddos.2005.11.001

M3 - Article

C2 - 16905449

AN - SCOPUS:33746885914

VL - 31

SP - 190

EP - 196

JO - Medical Dosimetry

JF - Medical Dosimetry

SN - 0958-3947

IS - 3

ER -